Patent · US Active

Method for correcting a genetic sequence

US10648002B2 · kind B2 · utility

0Cited by

0References

20Claims

0Family size

Assignee

Regents of the University of Minnesota · US

Inventors

Beau Webber · Coon Rapids, US
Mark J. Osborn · Minneapolis, US
Jakub Tolar · Minneapolis, US
Bruce R. Blazar · Golden Valley, US

Key dates

Filing date	Nov 22, 2017
Grant date	May 12, 2020
Priority date	—
Expiry date	Jul 20, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/18843
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Methods of gene correction, methods of generating induced pluripotent stem cells (iPSCs), and methods of deriving multi-lineage cell types with therapeutic value. In some embodiments, the gene correction affects the expression and/or function of the functional type VII collagen protein (C7).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.